[Chances and risks of anti-VEGF therapy]

MLA

F, Ziemssen, et al. “[Chances and Risks of Anti-VEGF Therapy].” Klinische Monatsblatter Fur Augenheilkunde, vol. 225, no. 9, Sept. 2008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........7791d84f29d42c469090470c922ce0fb&authtype=sso&custid=ns315887.

APA

F, Z., P, H., S, P., S, G., & U, S. (2008). [Chances and risks of anti-VEGF therapy]. Klinische Monatsblatter Fur Augenheilkunde, 225(9).

Chicago

F, Ziemssen, Heiduschka P, Peters S, Grisanti S, and Schraermeyer U. 2008. “[Chances and Risks of Anti-VEGF Therapy].” Klinische Monatsblatter Fur Augenheilkunde 225 (9). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........7791d84f29d42c469090470c922ce0fb&authtype=sso&custid=ns315887.